84
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBETATAG retinal tumors

, , , , , , , , , & show all
Pages 337-343 | Published online: 07 Mar 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Radhika Manukonda, Revu VL Narayana, Swathi Kaliki, Dilip K Mishra & Geeta K Vemuganti. (2022) Emerging therapeutic targets for retinoblastoma. Expert Opinion on Therapeutic Targets 26:11, pages 937-947.
Read now
Samuel K Houston, Theodore J Lampidis & Timothy G Murray. (2013) Models and discovery strategies for new therapies of retinoblastoma . Expert Opinion on Drug Discovery 8:4, pages 383-394.
Read now
Yolanda Piña, Samuel K Houston, Timothy G Murray, Tulay Koru-Sengul, Christina Decatur, William K Scott, Lubov Nathanson, Jennifer Clarke & Theodore J Lampidis. (2012) Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETATAG retinal tumors. Clinical Ophthalmology 6, pages 817-830.
Read now